Pancreatic Cancer Research

ResearcherTongji UniversityActive in the last 2 years

Feng Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4068-3339; OpenAlex author ID A5023828770. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
31
Papers, trials and grants by year

2011: 3 papers · 2012: 1 paper · 2013: none · 2014: none · 2015: 1 paper · 2016: none · 2017: none · 2018: 2 papers · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: 1 paper · 2025: 1 paper · 2026: 1 paper

Papers 10

  1. SMAD4 Palmitoylation Drives a Metabolic-Transcriptional Circuit to Promote Tumorigenesis and Confers Radiosensitivity in Pancreatic Cancer. Last author DOI 10.1002/advs.202519791↗
  2. SMAD4 depletion enhances NHEJ by regulating BRCA1 expression through ARIH1 in pancreatic cancer. Last author DOI 10.1016/j.apsb.2025.03.035↗
  3. SMAD4 Limits PARP1 dependent DNA Repair to Render Pancreatic Cancer Cells Sensitive to Radiotherapy. Last author DOI 10.1038/s41419-024-07210-7↗
  4. SMAD4 Gene Mutation Renders Pancreatic Cancer Resistance to Radiotherapy through Promotion of Autophagy. Co-author DOI 10.1158/1078-0432.ccr-17-3435↗
  5. Antitumor effect of gemcitabine-loaded albumin nanoparticle on gemcitabine-resistant pancreatic cancer induced by low hENT1 expression. First author DOI 10.2147/ijn.s166769↗
  6. Downregulation of CD9 promotes pancreatic cancer growth and metastasis through upregulation of epidermal growth factor on the cell surface. Co-author DOI 10.3892/or.2015.3960↗
  7. Prognostic significance of annexin A1 expression in pancreatic ductal adenocarcinoma. Co-author DOI 10.7314/apjcp.2012.13.9.4707↗
  8. Resveratrol inhibits proliferation and induces apoptosis through the hedgehog signaling pathway in pancreatic cancer cell. Co-author DOI 10.1159/000333542↗
  9. Identification of RegIV as a novel GLI1 target gene in human pancreatic cancer. Co-author DOI 10.1371/journal.pone.0018434↗
  10. Expression of DNMT1 and DNMT3a are regulated by GLI1 in human pancreatic cancer. First author DOI 10.1371/journal.pone.0027684↗

Closest collaborators

The 25 strongest of 31 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yang Wang · 3 shared papers, 2024–2026 · strength 0.70
  2. Yiran Song · 2 shared papers, 2024–2025 · strength 0.46
  3. Yang Shi · 1 shared paper, 2025 · strength 0.26
  4. Chongyi Jiang · 1 shared paper, 2026 · strength 0.24
  5. Xiaobing Li · 1 shared paper, 2024 · strength 0.21
  6. Xingpeng Wang · 4 shared papers, 2011–2012 · strength 0.12
  7. Lie Yao · 1 shared paper, 2018 · strength 0.09
  8. Chen Jin · 1 shared paper, 2018 · strength 0.09
  9. Zhongyi Guo · 1 shared paper, 2018 · strength 0.09
  10. Xinzhe Yu · 1 shared paper, 2018 · strength 0.09
  11. Di Yang · 1 shared paper, 2018 · strength 0.09
  12. Deliang Fu · 1 shared paper, 2018 · strength 0.09
  13. Xuanfu Xu · 3 shared papers, 2011 · strength 0.08
  14. Chuanyong Guo · 3 shared papers, 2011 · strength 0.08
  15. Mauro Ferrari B · 1 shared paper, 2018 · strength 0.07
  16. Ya’an Kang · 1 shared paper, 2018 · strength 0.07
  17. Haifa Shen · 1 shared paper, 2018 · strength 0.07
  18. Xiaojun Xia · 1 shared paper, 2018 · strength 0.07
  19. Jason B. Fleming · 1 shared paper, 2018 · strength 0.07
  20. Eugene Jon Koay · 1 shared paper, 2018 · strength 0.07
  21. Wenhui Mo · 2 shared papers, 2011 · strength 0.05
  22. Maochun Tang · 1 shared paper, 2015 · strength 0.05
  23. Yan Fang Zhao · 1 shared paper, 2015 · strength 0.05
  24. Congying Chen · 1 shared paper, 2015 · strength 0.05
  25. Hua Liu · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.